Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Wed 29 Feb 2012, 17:30 ADW - Afdawn - Disposal of Dumont Healthcare (Pty) Limited by Afdawn to Gambassi
ADW
ADW                                                                             
ADW - Afdawn - Disposal of Dumont Healthcare (Pty) Limited by Afdawn to Gambassi
Tiles (Pty) Limited.                                                            
AFRICAN DAWN CAPITAL LIMITED                                                    
(Incorporated in the Republic of South Africa)                                  
(Registration number 1998/020520/06)                                            
JSE code: ADW                                                                   
ISIN: ZAE000060703                                                              
("Afdawn" or "the company" or "the Group")                                      
DISPOSAL OF DUMONT HEALTHCARE (PTY) LIMITED BY AFDAWN TO GAMBASSI TILES (PTY)   
LIMITED.                                                                        
1.Introduction                                                                  
Shareholders are advised that Afdawn has entered into a sale agreement with     
Gambassi Tiles (Pty) Limited ("Gambassi")("the purchaser") to dispose of the    
entire issued share capital of Dumont Healthcare (Pty) Limited ("Dumont"), a    
wholly owned subsidiary of Afdawn and the cession of the loans against Afdawn   
for a cash consideration of R1 900 000 ("the disposal").                        
One of the shareholder of Gambassi is Corne van den Berg, the Managing Director 
of Dumont, a related party within the Group.                                    
1.2 The effective date                                                          
The effective date of the disposal is 29 February 2012.                         
1.3 Consideration of the disposal                                               
The cash consideration of the disposal is R1 900 000, to be settled by 29       
February 2012 as follows:                                                       
- R100 in terms the shares; and                                                 
- The balance of R1 899 900 in terms of Afdawn`s loan                           
The cash proceeds after the settlement of the disposal will be utilised to fund 
existing operations and to grow Elite Medical Finance.                          
2. Rationale for the disposal                                                   
The disposal is part of the Afdawn strategy to rationalise and consolidate cost 
within the Group. Dumont is operating on a small active customer base in        
Pretoria with a high cost to income ratio resulting in losses. Strategically the
current operating model requires a radical revamp enabling a low cost           
infrastructure with the flexibility to significantly scale operations. In       
addition the new business model will contribute to the value chain in providing 
funding to the Elite target market. Corne van den Berg believes the current     
operating model is sustainable and was willing to purchase Dumont.              
3. Conditions precedent                                                         
The disposal is subject to the transfer of shares into the name of Gambassi and 
the resignation of the directors previously appointed by Afdawn to Dumont Board.
In the event of non-payment, Dumont will remain a wholly owned subsidiary of    
Afdawn.                                                                         
4. Warranties                                                                   
The shares and the cession of the seller`s loans are sold "as is" and no        
warranties are to be provided by Afdawn to the purchaser.                       
5. Pro forma financial effects of the disposal                                  
The unaudited pro forma financial effects of the disposal are set out below.    
The unaudited pro forma financial effects have been prepared for illustrative   
purposes only to provide information on how the disposal may have impacted on   
the results and financial position of Afdawn.  Preparation of the unaudited pro 
forma financial effects is the responsibility of the directors.  Because of     
their nature, the unaudited pro forma financial effects may not fairly present  
Afdawn`s financial position after the disposal or the effects on future         
earnings:                                                                       
                            Interims  as                                        
                            at 31 August                                        
2011                                                
                            Before 1                  Percentage                
                                          After       change                    
                                                      %                         
Earnings per share           1.71          1.86        +9%                      
(cents)2                                                                        
Headline earnings            1.80          1.87        +4%                      
per share (cents)2                                                              
Net asset value (cents per   13.41         13.36       -0.3%                    
share)3                                                                         
Net tangible asset value     13.41         13.36       -0.3%                    
(cents per share)3                                                              
Number of shares in issue    22 926        22 926      -                        
(`000)                                                                          
Weighted average number of   22 926        22 926      -                        
share in issue (`000)                                                           
Notes and assumptions:                                                          
1. It has been assumed for purposes of the unaudited pro forma adjustments on   
Earnings per Share and Headline earnings per share that the disposal took place 
with effect from 1 March 2011 and at 28 February 2011 for unaudited pro forma   
adjustment on Net asset value and Net tangible asset value.                     
2. The adjustment on Earnings per share relates to reversal of Dumont loss (1   
March 2011 - 31 August 2011) and calculated profit on sale as at 1 March 2011.  
3. The adjustment on Net asset value relates to the calculated loss on sale as  
at 31 August 2011.                                                              
6. Small related party transaction                                              
As Dumont is a wholly owned subsidiary of Afdawn, Dumont and Gambassi are       
therefore related parties in terms of the JSE Limited ("the JSE") Listings      
Requirements as Corne van den Berg is a director of Dumont as well as a director
and shareholder of Gambassi. This disposal is therefore classified as a small   
related party transaction in relation to Afdawn. The JSE Listings Requirements  
require written confirmation from an Independent professional expert that the   
disposal is fair to Afdawn shareholders.  Bridge Capital Advisors (Pty) Limited 
has confirmed that the disposal is fair to Afdawn shareholders and their        
fairness opinion is available for inspection at Afdawn`s registered offices.    
29 February 2012                                                                
Johannesburg                                                                    
Designated Advisor                                                              
Sasfin Capital                                                                  
(a division of Sasfin Bank Limited)                                             
Date: 29/02/2012 17:30:01 Produced by the JSE SENS Department.                  
The SENS service is an information dissemination service administered by the    
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or            
implicitly, represent, warrant or in any way guarantee the truth, accuracy or   
completeness of the information published on SENS. The JSE, their officers,     
employees and agents accept no liability for (or in respect of) any direct,     
indirect, incidental or consequential loss or damage of any kind or nature,     
howsoever arising, from the use of SENS or the use of, or reliance on,          
information disseminated through SENS.                                          
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: